Abiopharma

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm

Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting

Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025

Update on ADR upgrade, Nasdaq uplisting

HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event

Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy

Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

ABBIE and the Future of Cancer Research

2025年Ecolab Watermark™ 研究揭示人工智能的隐性影响

Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05